Argosy Research Inc. (TPEX:3217)
Taiwan · Delayed Price · Currency is TWD 190.50
+2.00 (1.06%)
May 29, 2026, 1:30 PM CST
Argosy Research Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,173 | 4,148 | 3,473 | 3,004 | 2,608 | 3,016 | |
Revenue Growth (YoY) | 12.33% | 19.44% | 15.64% | 15.15% | -13.53% | 16.09% |
Cost of Revenue | 2,104 | 2,079 | 1,736 | 1,602 | 1,583 | 1,746 |
Gross Profit | 2,069 | 2,069 | 1,738 | 1,401 | 1,025 | 1,270 |
Selling, General & Admin | 510.75 | 517.49 | 449.99 | 379.89 | 301.26 | 308.93 |
Research & Development | 249.87 | 250.04 | 226.41 | 194.75 | 183.96 | 176.48 |
Operating Expenses | 760.62 | 763.02 | 680.9 | 574.58 | 485.28 | 485.33 |
Operating Income | 1,308 | 1,306 | 1,057 | 826.85 | 539.68 | 785.03 |
Interest Expense | -0.22 | -0.23 | -0.25 | -0.68 | -0.31 | -0.2 |
Interest & Investment Income | 67.09 | 65.71 | 74.75 | 54 | 49.34 | 31.99 |
Currency Exchange Gain (Loss) | -10.08 | -10.08 | 84.17 | 2.02 | 147.65 | -22.87 |
Other Non Operating Income (Expenses) | 36.81 | 58.31 | 15.24 | 41.95 | 24.17 | 19.75 |
EBT Excluding Unusual Items | 1,402 | 1,420 | 1,231 | 924.14 | 760.53 | 813.7 |
Impairment of Goodwill | - | - | - | - | - | -10.23 |
Gain (Loss) on Sale of Assets | 23.02 | 23.02 | 34.58 | -0.01 | 0.1 | 2.36 |
Other Unusual Items | 0.02 | 0.02 | - | - | - | - |
Pretax Income | 1,425 | 1,443 | 1,265 | 924.13 | 760.63 | 805.83 |
Income Tax Expense | 294.75 | 300.06 | 252.04 | 195.46 | 149.96 | 166.78 |
Earnings From Continuing Operations | 1,130 | 1,143 | 1,013 | 728.68 | 610.67 | 639.06 |
Minority Interest in Earnings | - | - | - | - | - | 1.17 |
Net Income | 1,130 | 1,143 | 1,013 | 728.68 | 610.67 | 640.22 |
Net Income to Common | 1,130 | 1,143 | 1,013 | 728.68 | 610.67 | 640.22 |
Net Income Growth | 4.62% | 12.80% | 39.07% | 19.32% | -4.62% | 4.66% |
Shares Outstanding (Basic) | 88 | 90 | 90 | 90 | 90 | 90 |
Shares Outstanding (Diluted) | 88 | 90 | 90 | 90 | 90 | 90 |
Shares Change (YoY) | -1.80% | -0.04% | 0.23% | 0.15% | -0.38% | 6.10% |
EPS (Basic) | 12.78 | 12.69 | 11.25 | 8.11 | 6.80 | 7.11 |
EPS (Diluted) | 12.78 | 12.69 | 11.25 | 8.11 | 6.80 | 7.11 |
EPS Growth | 6.54% | 12.85% | 38.75% | 19.14% | -4.25% | -1.36% |
Free Cash Flow | 919.48 | 1,043 | 899.26 | 544.2 | 730.19 | 270.01 |
Free Cash Flow Per Share | 10.39 | 11.58 | 9.98 | 6.05 | 8.13 | 3.00 |
Dividend Per Share | - | - | 8.813 | 6.400 | 5.350 | 5.600 |
Dividend Growth | - | - | 37.70% | 19.63% | -4.46% | - |
Gross Margin | 49.59% | 49.88% | 50.03% | 46.66% | 39.30% | 42.11% |
Operating Margin | 31.36% | 31.49% | 30.43% | 27.53% | 20.69% | 26.02% |
Profit Margin | 27.09% | 27.55% | 29.18% | 24.26% | 23.41% | 21.22% |
Free Cash Flow Margin | 22.04% | 25.15% | 25.89% | 18.12% | 27.99% | 8.95% |
EBITDA | 1,425 | 1,424 | 1,188 | 951.6 | 660.9 | 894.55 |
EBITDA Margin | 34.16% | 34.32% | 34.19% | 31.68% | 25.34% | 29.66% |
D&A For EBITDA | 116.79 | 117.23 | 130.63 | 124.75 | 121.22 | 109.53 |
EBIT | 1,308 | 1,306 | 1,057 | 826.85 | 539.68 | 785.03 |
EBIT Margin | 31.36% | 31.49% | 30.43% | 27.53% | 20.69% | 26.02% |
Effective Tax Rate | 20.68% | 20.79% | 19.92% | 21.15% | 19.71% | 20.70% |